SY

Sajal Yogi

Active Director Director DIN 07744252
DIN 07744252 First appointment Mar 2017 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2017
Shareholding value •••• Premium profile

About Sajal Yogi

Data last updated:

Sajal Yogi is a Director at Medisar Pharmaceuticals Private Limited (since 2017). The company operates in Business Services. Medisar Pharmaceuticals Private Limited reported revenue of ₹11.8 Lakh (FY 2019).

DIN 07744252
Primary Designation Director
Industry Business Services
First Appointment 15 Mar 2017
Oldest Company Age 9 yrs
Largest company Medisar Pharmaceuticals Private Limited · ₹11.8 Lakh (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Mar 20172017₹11.8 Lakh (FY 2019)Active

Board colleagues of Sajal Yogi

Directorship timeline

Open interactive timeline →
Medisar Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sajal Yogi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sajal Yogi

Sajal Yogi currently holds 1 directorship: Medisar Pharmaceuticals Private Limited (Director, since 15 Mar 2017, revenue ₹11.8 Lakh (FY 2019)).

Sajal Yogi was first appointed on 15 Mar 2017 as Director at Medisar Pharmaceuticals Private Limited.

The current boards of Sajal Yogi's companies include Arjun Kirar (Medisar Pharmaceuticals Private Limited), Nand Kishor Kirar (Medisar Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available